The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.00
Bid: 10.50
Ask: 11.50
Change: -0.25 (-2.22%)
Spread: 1.00 (9.524%)
Open: 11.25
High: 11.05
Low: 10.50
Prev. Close: 11.25
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Innovative Eyewear Inc. Closing of US $ 7.35 M IPO

18 Aug 2022 07:00

RNS Number : 3765W
Tekcapital plc
18 August 2022
 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

18 August 2022

Tekcapital Plc

("Tekcapital", the "Company" or the "Group")

Portfolio Company Update: Lucyd Ltd ("Lucyd")

Innovative Eyewear, Inc. Announces Closing of $7.35 Million Initial Public Offering

 

Tekcapital Plc (AIM: TEK, OTCQB: TEKCF), the UK intellectual property investment group focused on transforming university technologies into valuable products that can improve people's lives, is pleased to announce that Innovative Eyewear Inc. a subsidiary of portfolio company Lucyd, has closed its US$7.35 million Initial Public Offering.

Innovative Eyewear, Inc. ("Innovative Eyewear") (NASDAQ: LUCY; LUCYW), a developer and retailer of cutting-edge eyeglasses and sunglasses designed to allow the users to remain connected to their digital lives, today announced the closing of its previously announced initial public offering of 980,000 units consisting of 980,000 shares of its common stock and 1,960,000 Warrants to purchase 1,960,000 shares of common stock at a combined offering price of $7.50 per unit, for gross proceeds of approximately $7.35 million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with two Warrants, each Warrant to purchase one share of common stock with an exercise price of $7.50 per share. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which Maxim Group LLC has exercised its option to purchase additional warrants to purchase 294,000 shares of common stock. 

The shares of common stock and warrants began trading on The Nasdaq Capital Market on August 15, 2022, under the symbols "LUCY" and "LUCYW," respectively. 

The Company intends to use substantially all of the net proceeds from the offering for advancing its sales and marketing, expanding inventory, updating and producing in-store displays, developing new styles and sizes of the Company's smart eyewear, and for working capital and other general corporate purposes.

Maxim Group LLC acted as the Sole book-running manager in connection with the offering.

A registration statement on Form S-1, as amended (File No. 333-261616) was filed with the Securities and Exchange Commission ("SEC"), which became effective on August 12, 2022. A final prospectus relating to the offering was filed with the SEC and is available on the SEC's website at http://www.sec.gov. The offering was made only by means of a prospectus forming part of the effective registration statement. Electronic copies of the prospectus relating to this offering, may be obtained from Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, New York 10022, at (212) 895-3745.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Innovative Eyewear, Inc.

Innovative Eyewear is a developer and retailer of smart eyewear, which are designed to allow the users to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company believes that traditional frames, no matter how attractive, do not possess the functionality that many eyeglass wearers need and want. Smart eyewear is a multifunctional product that addresses the needs of the optical, hearables and digital assistant markets. We believe that the Company's products are well positioned in this rapidly growing wearables ecosystem, with the mission to Upgrade Your Eyewear®. For more information, please visit www.lucyd.co.

 

Tekcapital currently owns 100% of the share capital of Lucyd Ltd and 5,189,086 shares (approximately 71% post-IPO) of its U.S. operating subsidiary, Innovative Eyewear, Inc.

For further information, please contact:

 

Tekcapital Plc 

Via Flagstaff

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP

(Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison/Charlie Bouverat (Corporate Finance)/Abigail Wayne / Rob Rees (Corporate Broking)

 

 

Flagstaff Strategic and Investor Communications

+44 (0) 20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

 

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

LEI: 213800GOJTOV19FIFZ85

Forward-Looking Statements

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Innovative Eyewear, Inc., Lucyd or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Tekcapital or Lucyd's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Innovative Eyewear Inc., Lucyd and/or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither Innovative Eyewear Inc, Lucyd nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSETIIDLIF
Date   Source Headline
31st Jan 20174:26 pmRNSTotal Voting Rights and Holding in Company
26th Jan 20173:00 pmRNSResults of proposed placing to raise £2.4m
26th Jan 20177:00 amRNSProposed placing
12th Jan 20177:00 amRNSNotice of Allowance for Energy Harvester Patent
4th Jan 20177:00 amRNSSuccessful Production and Testing of µSaltTM
28th Dec 20167:00 amRNSOut-licence & Strategic Alliance with Wecast
9th Nov 20167:00 amRNSDirectorate Change
31st Oct 20167:00 amRNSStrategic Alliance with Bajainnova SAPI de CV
28th Oct 20167:00 amRNSNotice of Allowance for 2nd Crackle-baked Patent
25th Oct 20167:00 amRNSPrivate Placement for Belluscura Ltd
7th Oct 20164:28 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSAcquisition of Medical Device Licence
31st Aug 20167:00 amRNSHalf-year Report
30th Jun 20167:30 amRNSGrant of Options
17th Jun 20167:00 amRNSPrivate Placement for Belluscura Ltd
6th Jun 201611:44 amRNSAcquisition of salt reduction technology patent
27th May 20162:47 pmRNSResult of AGM
4th May 20167:00 amRNSPosting of Annual Report and Notice of AGM
29th Apr 20167:00 amRNSFinal Results
28th Apr 20167:00 amRNSAcquisition and Total Voting Rights
20th Apr 201612:53 pmRNSHolding(s) in Company
13th Apr 20167:00 amRNSAcquisition of Medical Devices
14th Mar 20167:00 amRNSNew Technology License
12th Feb 20167:00 amRNSDirectorate Change
12th Jan 20167:00 amRNSTekcapital Chairman announced as award finalist
4th Jan 20163:06 pmRNSHolding(s) in Company
24th Dec 20157:00 amRNSAcquisition of Energy Harvesting Technology
22nd Dec 201512:52 pmRNSHolding(s) in Company
30th Nov 20155:30 pmRNSTotal Voting Rights
24th Nov 20152:14 pmRNSExercise of warrants and total voting rights
23rd Nov 20157:00 amRNSPatent Update for Crackle-baked(R) Technology
13th Nov 20159:15 amRNSHolding(s) in Company
10th Nov 20157:00 amRNSDirectorate Change
9th Nov 20157:00 amRNSNew Patent Application
9th Oct 20157:00 amRNSHolding(s) in Company
28th Aug 20155:00 pmRNSTotal Voting Rights
20th Aug 20157:00 amRNSHalf Yearly Report
14th Aug 20157:00 amRNSAcquisition of air conditioning efficiency patents
29th Jun 20157:00 amRNSAcquisition of energy harvesting technologies
22nd Jun 20154:27 pmRNSHolding(s) in Company
12th Jun 201511:52 amRNSResult of General Meeting
8th Jun 20157:00 amRNSGrant of Share Options
29th May 20156:15 pmRNSHolding(s) in Company
29th May 20156:15 pmRNSTotal Voting Rights
29th May 20151:13 pmRNSResult of AGM
21st May 201512:52 pmRNSFinal Results
14th May 20154:07 pmRNSHolding(s) in Company
13th May 20157:00 amRNSHolding(s) in Company
12th May 20152:00 pmRNSHolding(s) in Company
12th May 20157:00 amRNSHolding in Company and Directorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.